Loading...
Tailoring therapy for ischemic cardiomyopathy: is Laplace’s law enough?
The burden of heart failure has long plagued the productive years of the population, with therapeutic advances in the timely treatment of ischemic heart disease decreasing its associated mortality. Angiotensin-converting enzyme inhibitors and β-blockers have impacted heart failure therapeutics in a...
Na minha lista:
| Udgivet i: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933553/ https://ncbi.nlm.nih.gov/pubmed/28689451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944717718719 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|